Albatroz Therapeutics

Albatroz Therapeutics is a Singapore-based biotechnology company that develops first-class antibody therapies for the treatment of solid tumors and arthritis diseases. This new technology was developed by the founding team of A*STAR's Institute of Molecular and Cell Biology. Established in 2020, the company holds exclusive licensing rights to a portfolio of patented technologies and is currently conducting further target validation, drug development, and preclinical research.